company background image
ELAN

Elanco Animal Health NYSE:ELAN Stock Report

Last Price

US$13.79

Market Cap

US$6.5b

7D

0.4%

1Y

-44.5%

Updated

07 Feb, 2023

Data

Company Financials +

Elanco Animal Health Incorporated

NYSE:ELAN Stock Report

Mkt Cap: US$6.5b

ELAN Stock Overview

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals.

ELAN fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Rewards

Trading at 74.2% below our estimate of its fair value

Earnings are forecast to grow 46.66% per year

Risk Analysis

No risks detected for ELAN from our risk checks.

My Notes

New

Notes are coming soon

Elanco Animal Health Incorporated Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Elanco Animal Health
Historical stock prices
Current Share PriceUS$13.79
52 Week HighUS$29.66
52 Week LowUS$11.18
Beta0.93
1 Month Change8.58%
3 Month Change14.34%
1 Year Change-44.53%
3 Year Change-56.57%
5 Year Changen/a
Change since IPO-61.69%

Recent News & Updates

Elanco's Tangible Equity Units: Living With The Worst Case

Dec 13

Recent updates

Elanco's Tangible Equity Units: Living With The Worst Case

Dec 13

We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Nov 08
We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Elanco Q3 2022 Earnings Preview

Nov 07

Elanco Animal Health: This 'Sick Dog' Should Recover

Oct 19

Elanco adds 9% as activist investor Sachem Head raises stake

Sep 09

Elanco Animal Health hits another 52-week low. What's going on with the company?

Aug 23

Elanco Animal Health hits 52-week low; down 33% YTD

Aug 16

Elanco Q2 2022 Earnings Preview

Aug 05

We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Jul 25
We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Elanco Animal Health: Bullish Beyond Near-Term 'Bird Flu' Headwinds

Apr 19

Is Elanco Animal Health (NYSE:ELAN) A Risky Investment?

Apr 13
Is Elanco Animal Health (NYSE:ELAN) A Risky Investment?

Elanco Animal Health: Getting Healthier, Slowly

Feb 02

We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

Jan 10
We Think Elanco Animal Health (NYSE:ELAN) Is Taking Some Risk With Its Debt

An Intrinsic Calculation For Elanco Animal Health Incorporated (NYSE:ELAN) Suggests It's 29% Undervalued

Sep 09
An Intrinsic Calculation For Elanco Animal Health Incorporated (NYSE:ELAN) Suggests It's 29% Undervalued

Elanco's Tangible Equity Units: Low-Risk Option With A 5% Yield

Aug 21

Does Elanco Animal Health (NYSE:ELAN) Have A Healthy Balance Sheet?

Jun 20
Does Elanco Animal Health (NYSE:ELAN) Have A Healthy Balance Sheet?

TriRx Pharma to acquire Elanco Animal's two facilities in Kansas and U.K.

Jun 15

An Intrinsic Calculation For Elanco Animal Health Incorporated (NYSE:ELAN) Suggests It's 40% Undervalued

May 12
An Intrinsic Calculation For Elanco Animal Health Incorporated (NYSE:ELAN) Suggests It's 40% Undervalued

Elanco Q1 2021 Earnings Preview

May 06

Elanco Animal Health (NYSE:ELAN) Seems To Be Using A Lot Of Debt

Mar 21
Elanco Animal Health (NYSE:ELAN) Seems To Be Using A Lot Of Debt

Need To Know: Elanco Animal Health Incorporated (NYSE:ELAN) Insiders Have Been Buying Shares

Feb 23
Need To Know: Elanco Animal Health Incorporated (NYSE:ELAN) Insiders Have Been Buying Shares

Elanco Animal Health: Investor Day Highlights Path Toward Closing The Valuation Gap

Jan 03

Elanco Animal Health Incorporated's (NYSE:ELAN) Intrinsic Value Is Potentially 65% Above Its Share Price

Jan 01
Elanco Animal Health Incorporated's (NYSE:ELAN) Intrinsic Value Is Potentially 65% Above Its Share Price

Elanco Animal Health (ELAN) Investor Presentation - Slideshow

Dec 16

Elanco upgrades revenue guidance; shares jump 6%

Dec 15

Elanco buys rights to KindredBio's canine parvovirus therapy

Dec 11

Elanco announces public offering of common stock by selling shareholder

Nov 30

Shareholder Returns

ELANUS PharmaceuticalsUS Market
7D0.4%-0.7%0.9%
1Y-44.5%4.9%-10.9%

Return vs Industry: ELAN underperformed the US Pharmaceuticals industry which returned 4.6% over the past year.

Return vs Market: ELAN underperformed the US Market which returned -9.6% over the past year.

Price Volatility

Is ELAN's price volatile compared to industry and market?
ELAN volatility
ELAN Average Weekly Movement6.7%
Pharmaceuticals Industry Average Movement11.5%
Market Average Movement6.7%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: ELAN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: ELAN's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19549,000Jeff Simmonshttps://www.elanco.com

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations.

Elanco Animal Health Incorporated Fundamentals Summary

How do Elanco Animal Health's earnings and revenue compare to its market cap?
ELAN fundamental statistics
Market CapUS$6.54b
Earnings (TTM)-US$120.00m
Revenue (TTM)US$4.54b

1.4x

P/S Ratio

-54.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ELAN income statement (TTM)
RevenueUS$4.54b
Cost of RevenueUS$1.91b
Gross ProfitUS$2.63b
Other ExpensesUS$2.75b
Earnings-US$120.00m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

Feb 21, 2023

Earnings per share (EPS)-0.25
Gross Margin57.89%
Net Profit Margin-2.64%
Debt/Equity Ratio87.5%

How did ELAN perform over the long term?

See historical performance and comparison